CRBP vs. SPY
CRBP (Corbus Pharmaceuticals Holdings, Inc.) is a stock, while SPY (State Street SPDR S&P 500 ETF) is S&P 500 fund tracking the S&P 500 Index. Over the past 10 years, CRBP returned -21.03%/yr vs 15.53%/yr for SPY. At a 0.26 correlation, their price movements are largely independent.
Performance
CRBP vs. SPY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRBP achieves a 3.93% return, which is significantly lower than SPY's 8.15% return. Over the past 10 years, CRBP has underperformed SPY with an annualized return of -21.03%, while SPY has yielded a comparatively higher 15.53% annualized return.
CRBP
- 1D
- 1.81%
- 1M
- -25.46%
- YTD
- 3.93%
- 6M
- 3.30%
- 1Y
- 7.22%
- 3Y*
- -1.27%
- 5Y*
- -32.88%
- 10Y*
- -21.03%
SPY
- 1D
- -1.45%
- 1M
- -1.36%
- YTD
- 8.15%
- 6M
- 7.20%
- 1Y
- 23.59%
- 3Y*
- 20.68%
- 5Y*
- 13.05%
- 10Y*
- 15.53%
CRBP vs. SPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CRBP Corbus Pharmaceuticals Holdings, Inc. | 3.93% | -31.02% | 95.36% | 82.20% | -82.05% | -50.74% | -77.11% | -6.51% | -17.75% | -15.98% |
SPY State Street SPDR S&P 500 ETF | 8.15% | 17.72% | 24.89% | 26.18% | -18.18% | 28.73% | 18.33% | 31.22% | -4.57% | 21.71% |
Correlation
The correlation between CRBP and SPY is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Nov 11, 2014 | 0.26 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRBP vs. SPY — Risk / Return Rank
CRBP
SPY
CRBP vs. SPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Corbus Pharmaceuticals Holdings, Inc. (CRBP) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRBP | SPY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.81 | ||
| Sortino ratioReturn per unit of downside risk | -1.87 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.34 | -0.24 |
| Calmar ratioReturn relative to maximum drawdown | 0.12 | 2.67 | -2.55 |
| Martin ratioReturn relative to average drawdown | 0.17 | 11.92 | -11.75 |
Loading charts...
Drawdowns
CRBP vs. SPY - Drawdown Comparison
The maximum CRBP drawdown since its inception was -99.31%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for CRBP and SPY.
Loading charts...
Drawdown Indicators
| CRBP | SPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.31% | -55.19% | -44.12% |
Max Drawdown (1Y)Largest decline over 1 year | -61.88% | -8.88% | -53.00% |
Max Drawdown (3Y)Largest decline over 3 years | -92.01% | -18.76% | -73.25% |
Max Drawdown (5Y)Largest decline over 5 years | -96.30% | -24.50% | -71.80% |
Max Drawdown (10Y)Largest decline over 10 years | -99.31% | -33.72% | -65.59% |
Current DrawdownCurrent decline from peak | -97.28% | -3.17% | -94.11% |
Average DrawdownAverage peak-to-trough decline | -66.12% | -9.04% | -57.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.01% | 1.98% | +40.03% |
Volatility
CRBP vs. SPY - Volatility Comparison
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a higher volatility of 39.34% compared to State Street SPDR S&P 500 ETF (SPY) at 4.87%. This indicates that CRBP's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRBP | SPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 39.34% | 4.87% | +34.47% |
Volatility (6M)Calculated over the trailing 6-month period | 60.28% | 9.85% | +50.43% |
Volatility (1Y)Calculated over the trailing 1-year period | 81.56% | 12.50% | +69.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 159.23% | 17.15% | +142.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 129.12% | 17.95% | +111.17% |
Dividends
CRBP vs. SPY - Dividend Comparison
CRBP has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.03%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRBP Corbus Pharmaceuticals Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY State Street SPDR S&P 500 ETF | 1.03% | 1.07% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% |
Frequently Asked Questions
CRBP and SPY have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRBP has higher volatility (39.34%) compared to SPY (4.87%). In terms of maximum drawdown, CRBP dropped -99.31% vs SPY's -55.19%.
SPY currently has the higher Sharpe Ratio (1.90 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRBP and SPY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer